跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,825 条关于
“Tempus ECG-AF”
全部
5,825
临床试验
4,565
药物
487
机构
311
资讯
462
4年前
Tempus Receives First FDA Clearance for AI-Based Atrial Fibrillation Risk Detection Algorithm
去年
Tempus AI Receives FDA 510(k) Clearance for ECG-Low EF Software to Detect Heart Failure Risk
去年
Tempus AI Reports Strong Growth and Strategic Acquisition of Ambry Genetics in Q4 2024
去年
Novel ECG Feature Analysis Reveals P-Wave Changes as Early Warning Sign for Atrial Fibrillation
2年前
GUARD-AF Trial: iRhythm's Zio XT Patch Increases AF Detection in Primary Care
去年
Remote ECG Patch Screening Shows Modest Increase in Atrial Fibrillation Detection in High-Risk Older Adults
去年
Linear Ablation with Ethanol Infusion Improves Outcomes in Persistent Atrial Fibrillation
去年
Linear Ablation Plus Vein of Marshall Ethanol Infusion Improves Outcomes in Persistent Atrial Fibrillation
4个月前
Discontinuing OAC After AF Catheter Ablation Reduces Bleeding Without Increasing Stroke Risk: ALONE-AF Trial
去年
BRAIN-AF: Rivaroxaban Fails to Reduce Cognitive Decline in Younger AF Patients
第 1 页,共 47 页
上一页
下一页